Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01092598 · ClinicalTrials.gov registry record

Factors Association With Poor Physical Function in Older Adults With Schizophrenia

A clinical trial, sponsored by University of California, San Francisco.

Completed
Registry status
46
Enrollment target

NCT01092598: Completed study, sponsored by University of California, San Francisco.

NCT01092598 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01092598 has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
46 participants
Enrollment target

Study Summary

Older adults with schizophrenia are a growing segment of the population yet their physical health status is poor. In order to design effective interventions, the contributing factors must be understood. Current data suggest the side effects of psychiatric medications, sociodemographic factors, and health care disparities are a few of the reasons for the poor physical health. There are only limited data on the impact of psychiatric symptomatology and neurocognition on the physical health of this population. These limited data indicate that worse symptomatology and poorer neurocognition may negatively impact physical functioning, a critical component to optimal physical health. The purpose of this pilot study is to begin to fill this knowledge gap by: 1. examining the relationship between neurocognitive function and physical function and 2. Examining the relationship between schizophrenia symptoms and physical function. 3. Examining the relationship between serum Brain Derived Neurotrophic Factor (BDNF) and physical function. Using a descriptive correlational design, 50 older adults (55+) with schizophrenia or schizoaffective disorder will be assessed. Bivariate associations will be used to examine the relationship between key variables including schizophrenia symptoms as measured by the Positive and Negative Syndrome Scale (PANSS), neurocognitive function as measured with the MATRICS Consensus Cognitive Battery (MCCB), Physical Function as measured objectively by the Timed Get Up and Go (TGUG) test and subjectively with the physical component summary subscale of the 12-item short form health survey (SF-12), and serum BDNF. These pilot data will lay the foundation for a future health promoting intervention.

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2010-03
Est. Completion 2015-05

What the finished NCT01092598 record still lists

NCT01092598 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01092598 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01092598 about?

NCT01092598 is a clinical study titled "Factors Association With Poor Physical Function in Older Adults With Schizophrenia". Older adults with schizophrenia are a growing segment of the population yet their physical health status is poor. In order to design effective interventions, the contributing factors must be understood. Current data suggest the side effects of psychiatric medications, sociodemographic factors, and h...

What is the current status of trial NCT01092598?

This trial is currently completed. The enrollment target is 46 participants. The study started on 2010-03. Estimated completion is 2015-05.

Who is sponsoring clinical trial NCT01092598?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01092598, the US trial registry maintained by the National Library of Medicine. NCT01092598 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.